Literature DB >> 17694599

Post-discharge symptomatic thromboembolic events in hip fracture patients.

Sanjeev Anand1, Keyur Buch.   

Abstract

INTRODUCTION: The aim of this study was to audit referral rates for post-discharge symptomatic thromboembolic events following hip fracture surgery to assess the extent of the clinical problem and to initiate discussion on prolonged chemoprophylaxis. PATIENTS AND METHODS: All patients who underwent surgery for proximal hip fractures in one year (2001-2002) were followed up. Patient case-notes were used to identify all morbidity episodes within 3 months following discharge. Patients with suspected symptomatic thromboembolic episodes were investigated to confirm the diagnoses objectively. Reasons for hospital readmission and causes of death were identified.
RESULTS: A total of 267 patients who underwent surgery for proximal hip fractures were included in the study. Forty-three patients died during initial admission episode. Of the 224 patients discharged, 46 (20.54%) patients were referred back to hospital within 3 months, for unplanned emergency management. Of these, 8 patients (3.57%) were referred back for suspected thromboembolic events. Of these, 6 (2.67%) were referred with a clinical diagnoses of deep vein thrombosis (DVT) but only 1 patient (0.45%) was confirmed to have DVT. Two patients (0.89%) were referred with features of pulmonary embolism (PE). Both were confirmed on ventilation-perfusion scans and both patients died. One patient died following PE in the community.Thus, overall, 3 deaths (1.34%) following discharge were recorded to be due to pulmonary embolism.
CONCLUSIONS: Suspected thromboembolic events constitute a major proportion of unplanned referrals back to the hospital. Three deaths due to delayed pulmonary embolism may justify prolonged universal chemoprophylaxis following hip fracture surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17694599      PMCID: PMC2048602          DOI: 10.1308/003588407X202065

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  19 in total

Review 1.  The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement.

Authors:  D Warwick; M M Samama
Journal:  J Bone Joint Surg Br       Date:  2000-05

Review 2.  Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery.

Authors:  W Gillespie; D Murray; P J Gregg; D Warwick
Journal:  J Bone Joint Surg Br       Date:  2000-05

Review 3.  Thromboembolic prophylaxis for patients with a fracture of the proximal femur.

Authors:  Craig J Della Valle; Edwin Mirzabeigi; Joseph D Zuckerman; Kenneth J Koval
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2002-01

4.  Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.

Authors: 
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

5.  Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

Authors:  B I Eriksson; K A Bauer; M R Lassen; A G Turpie
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

6.  Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.

Authors:  P C Comp; T E Spiro; R J Friedman; T L Whitsett; G J Johnson; G A Gardiner; G C Landon; M Jové
Journal:  J Bone Joint Surg Am       Date:  2001-03       Impact factor: 5.284

7.  Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery.

Authors:  H W Thaler; R E Roller; N Greiner; E Sim; C Korninger
Journal:  J Trauma       Date:  2001-09

8.  Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

Authors:  Bengt I Eriksson; Michael R Lassen
Journal:  Arch Intern Med       Date:  2003-06-09

Review 9.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

10.  A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.

Authors:  P J Powers; M Gent; R M Jay; D H Julian; A G Turpie; M Levine; J Hirsh
Journal:  Arch Intern Med       Date:  1989-04
View more
  7 in total

1.  Impact of type of surgery on deep venous thrombi and pulmonary emboli: a look at twenty seven thousand hip fracture patients.

Authors:  Vasanth Sathiyakumar; Sarah E Greenberg; Alex A Jahangir; Hassan H Mir; William T Obremskey; Manish K Sethi
Journal:  Int Orthop       Date:  2015-07-09       Impact factor: 3.075

Review 2.  Post-discharge complications in postoperative patients with hip fracture.

Authors:  Umi Istianah; Intansari Nurjannah; Rahadyan Magetsari
Journal:  J Clin Orthop Trauma       Date:  2020-10-24

3.  Morbidity following lower extremity fractures in men with spinal cord injury.

Authors:  L D Carbone; A S Chin; S P Burns; J N Svircev; H Hoenig; M Heggeness; F Weaver
Journal:  Osteoporos Int       Date:  2013-02-08       Impact factor: 4.507

Review 4.  Increased fracture rate in women with breast cancer: a review of the hidden risk.

Authors:  Jean-Jacques Body
Journal:  BMC Cancer       Date:  2011-08-29       Impact factor: 4.430

5.  Bone marrow stem cells added to a hydroxyapatite scaffold result in better outcomes after surgical treatment of intertrochanteric hip fractures.

Authors:  Joao Torres; Manuel Gutierres; M Ascenção Lopes; J Domingos Santos; A T Cabral; R Pinto; Carola van Eck
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

6.  Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.

Authors:  Edoardo Colzani; Mark Clements; Anna L V Johansson; Annelie Liljegren; Wei He; Judith Brand; Jan Adolfsson; Tommy Fornander; Per Hall; Kamila Czene
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

Review 7.  Scoping review of potential quality indicators for hip fracture patient care.

Authors:  Kristen B Pitzul; Sarah E P Munce; Laure Perrier; Lauren Beaupre; Suzanne N Morin; Rhona McGlasson; Susan B Jaglal
Journal:  BMJ Open       Date:  2017-03-21       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.